Clinical trial
Efficacy and Safety of Low-dose Esketamine Combined With Target-controlled Infusion of Propofol for Painless Gastrointestinal Endoscopy and Polypectomy
NCT04691076 is registered in ClinicalTrials.gov with Tianjin Union Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Low-dose Esketamine Combined With Target-controlled Infusion of Propofol for Painless Gastrointestinal Endoscopy and Polypectomy
- Lead sponsor
- Tianjin Union Medical Center
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 1, 2020
- Completion date
- February 1, 2022
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anesthesia, pain